CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2a Study of Daclatasvir in Combination With Peginterferon Alfa-2a(Pegasys®) and Ribavirin (Copegus®) in Japanese Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01017575
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:51.144682+00:00
Published At: 2015-09-11T00:00:00+00:00
Record Updated At: 2015-09-11
Results Posted At: 2015-09-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-09-11"
protocolSection.identificationModule.nctId: "NCT01017575"
protocolSection.identificationModule.officialTitle: "A Phase 2a Study of Daclatasvir in Combination With Peginterferon Alfa-2a(Pegasys\u00ae) and Ribavirin (Copegus\u00ae) in Japanese Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-09-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.